Icobit MR 200mg Tablet SR
Marketer
Cubit Healthcare
Salt Composition
Aceclofenac (200mg)
Overview Icobit MR 200mg Tablet SR
Rilma 200mg Extended-Release Tablets provide analgesia and anti-inflammatory relief. Effective for managing pain and inflammation associated with rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis, Rilma should be administered precisely as directed by your physician. For optimal gastrointestinal tolerance, it is recommended to take this medication with food or milk. Potential side effects may encompass dizziness, dyspepsia, nausea, diarrhea, abdominal discomfort, and elevated liver enzymes. Prolonged therapy may necessitate routine monitoring of renal and hepatic function, as well as blood parameters. Chronic use carries the risk of significant complications, including gastrointestinal hemorrhage and nephrotoxicity.
Primary Ingredients of Icobit MR 200mg Tablet SR
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Icobit MR 200mg Tablet SR
Analgesia
Major Benefits of Icobit MR 200mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or fracturing it. The Icobit MR 200mg sustained-release tablet should be taken with a meal.
Common Side effects of Icobit MR 200mg Tablet SR:
- Dizziness
- Indigestion
- Nausea
- Abdominal pain
- Increased liver enzymes
How to use Icobit MR 200mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Icobit MR 200mg Sustained-Release Tablets should be administered with food.
How Icobit MR 200mg Tablet SR works:
Icobit MR 200mg Extended-Release Tablets are a non-steroidal anti-inflammatory drug (NSAID) that inhibits the production of inflammatory mediators responsible for pain and associated swelling and redness.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Icobit MR 200mg Tablet SR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Icobit MR 200mg sustained-release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Icobit MR 200mg sustained-release tablets with breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving should be avoided if you experience drowsiness, dizziness, blurred vision, or reduced alertness after taking Icobit MR 200mg sustained-release tablets.
KidneyCAUTION
Patients with impaired kidney function should use Icobit MR 200mg sustained-release tablets cautiously, potentially requiring dose modification. Consult a physician before use. Icobit MR 200mg sustained-release tablets are contraindicated in individuals with severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should use Icobit MR 200mg sustained-release tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended. This medication is contraindicated in patients exhibiting severe liver dysfunction. Routine monitoring of liver enzyme levels is advised during treatment.
What if you forget to take Icobit MR 200mg Tablet SR :
Should you forget to take your Icobit MR 200mg Tablet SR, administer it immediately upon remembering. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Icobit MR 200mg Tablet SR
| Label | Value |
|---|---|
| Chemical Category | Diclorobenzene derivative |
| Developing Habits | No. |
| Treatment Category | Pain Relievers |
| Actions | Nonselective COX-1 and COX-2 inhibitors (acetic acid derivatives) |
3,018 People bought this recently